SCHEMBL29418802

SCHEMBL29418802

Nc1cccc2c(Cl)cccc12

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR4A2 P43354 3/20 1.00
ALDH1A1 P00352 5/20 0.68
TSHR P16473 4/20 0.68
CYP1A2 P05177 3/20 0.68
CYP2A6 P11509 3/20 0.68
CYP3A4 P08684 3/20 0.68
HPGD P15428 3/20 0.68
HSD17B10 Q99714 2/20 0.68
TDP1 Q9NUW8 2/20 0.68
KEAP1 Q14145 1/20 0.50
KDM4E B2RXH2 2/20 0.48
MEN1 O00255 2/20 0.48
MAPT P10636 2/20 0.48
KMT2A Q03164 2/20 0.48
IDO1 P14902 2/20 0.48
USP2 O75604 1/20 0.48
TDP2 O95551 1/20 0.48
POLB P06746 1/20 0.48
TDO2 P48775 1/20 0.48
BLM P54132 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3183644 1.00 NR4A2 (1.00) NR4A2ALDH1A1TSHRCYP1A2CYP2A6
SCHEMBL1024142 0.84 NR4A2 (0.73) NR4A2ALDH1A1TSHRCYP1A2CYP2A6
SCHEMBL31499475 0.84 NR4A2 (0.73) NR4A2ALDH1A1TSHRCYP1A2CYP2A6
SCHEMBL2468811 0.83 CYP1A2 (1.00) NR4A2ALDH1A1TSHRCYP1A2CYP2A6
SCHEMBL29365003 0.83 ALDH1A1 (1.00) NR4A2ALDH1A1TSHRCYP3A4HPGD
SCHEMBL29629127 0.83 CYP1A2 (1.00) NR4A2ALDH1A1TSHRCYP1A2CYP2A6
SCHEMBL48843 0.83 ALDH1A1 (1.00) NR4A2ALDH1A1TSHRCYP3A4HPGD
Ammonia Solution, Strong SCHEMBL7197839 0.80 ALDH1A1 (0.93) NR4A2ALDH1A1TSHRCYP1A2CYP3A4
Hydrochloric Acid SCHEMBL8641121 0.80 CYP3A4 (0.93) NR4A2ALDH1A1TSHRCYP3A4HPGD
SCHEMBL335367 0.80 ALDH1A1 (0.93) NR4A2ALDH1A1TSHRCYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4329757-A1 HETEROCYCLIC COMPOUNDS AND METHODS OF USE Amgen Inc. (US) 2024-03-06 EP disclosed
EP-4322954-A1 SMALL MOLECULE INHIBITORS OF KRAS G12D MUTANT Merck Sharp & Dohme LLC (US) 2024-02-21 EP disclosed
EP-4240489-A1 KRAS G12D INHIBITORS Mirati Therapeutics, Inc. (US) 2023-09-13 EP disclosed
EP-4216951-A1 KRAS G12D INHIBITORS Mirati Therapeutics, Inc. (US) 2023-08-02 EP disclosed
EP-4192585-A1 KRAS G12D INHIBITORS Mirati Therapeutics, Inc. (US) 2023-06-14 EP disclosed
WO-2022232331-A1 HETEROCYCLIC COMPOUNDS AND METHODS OF USE AMGEN INC. (US) 2022-11-03 WO disclosed
WO-2022221739-A1 SMALL MOLECULE INHIBITORS OF KRAS G12D MUTANT MERCK SHARP & DOHME CORP. (US) 2022-10-20 WO disclosed
WO-2022098625-A1 KRAS G12D INHIBITORS Mirati Therapeutics, Inc. (US) 2022-05-12 WO disclosed
WO-2022066646-A1 KRAS G12D INHIBITORS Mirati Therapeutics, Inc. (US) 2022-03-31 WO disclosed
WO-2022031678-A1 KRAS G12D INHIBITORS Mirati Therapeutics, Inc. (US) 2022-02-10 WO disclosed